Artia Global Partners »

Verona Pharma Plc ads shares owned by Artia Global Partners

Quarter-by-quarter ownership of Verona Pharma Plc ads (VRNA) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Verona Pharma Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Verona Pharma Plc ads held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verona Pharma Plc ads by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 131k 19.88
2023-03-31 $1.8M 91k 20.08
2022-12-31 $1.0M 40k 26.13

More positions owned by Artia Global Partners

Novo-nordisk A S Adr (NVO)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Cytokinetics Call Call Option
Cytokinetics Put Put Option
Eli Lilly & Co Put Put Option
Abbvie (ABBV)
Argenx Se Sponsored Adr (ARGX)
Astrazeneca Sponsored Adr (AZN)
Viking Therapeutics (VKTX)
Axsome Therapeutics (AXSM)
Neurocrine Biosciences (NBIX)
Intra Cellular Therapies (ITCI)
BioMarin Pharmaceutical (BMRN)
Cytokinetics Com New (CYTK)

View all positions for Artia Global Partners

Top funds holding Verona Pharma Plc ads

RA Capital Management
NEA Management Company
Perceptive Advisors
Wellington Management Company
OrbiMed Advisors
Vivo Capital
Frazier Life Sciences Management
Federated Investors
Carlyle
Octagon Capital Advisors
Henderson Group
Maverick Capital
Jennison Associates
Eventide Asset Management
First Turn Management

View all funds holding Verona Pharma Plc ads